Sale!

MT-TI Gene Cardiomyopathy fatal MT-TI related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MT-TI gene, known for its crucial role in mitochondrial function, has been linked to certain types of cardiomyopathy, a disease of the heart muscle that can lead to heart failure and other serious conditions. Identifying mutations in the MT-TI gene can be essential for diagnosing mitochondrial cardiomyopathy, enabling targeted treatment and management of the condition.

DNA Labs UAE offers a specialized genetic test to detect mutations in the MT-TI gene, aiding in the diagnosis of cardiomyopathy related to this gene. The test is priced at 4400 AED and is conducted in their state-of-the-art laboratory facilities. By undergoing this test, individuals who have a family history of cardiomyopathy or have symptoms related to heart muscle dysfunction can gain valuable insights into their genetic predisposition towards this condition. Early detection through the MT-TI related genetic test can be critical in managing the disease effectively, potentially improving the quality of life and outcomes for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MT-TI Gene Cardiomyopathy: Fatal MT-TI Related Genetic Test

Test Details:

MT-TI gene cardiomyopathy is a type of cardiomyopathy that is caused by mutations in the MT-TI gene. This gene provides instructions for making a type of RNA molecule called transfer RNA (tRNA), which is essential for protein synthesis within mitochondria.

Cardiomyopathy is a disease of the heart muscle that affects its structure and function, leading to symptoms such as fatigue, shortness of breath, and heart failure. In the case of MT-TI gene cardiomyopathy, the mutations in the MT-TI gene disrupt the normal function of tRNA, impairing protein synthesis within mitochondria and leading to mitochondrial dysfunction.

MT-TI related NGS genetic testing refers to Next-Generation Sequencing (NGS) technology used to analyze the DNA sequence of the MT-TI gene. This genetic test can identify mutations or variations in the MT-TI gene that may be associated with cardiomyopathy. By detecting these mutations, the test can help diagnose MT-TI gene cardiomyopathy and provide valuable information for treatment and management of the condition.

It is important to note that MT-TI gene cardiomyopathy is a fatal condition, meaning it can lead to severe complications and premature death. Early diagnosis through genetic testing can help guide appropriate medical interventions and monitoring to improve patient outcomes.

Test Name: MT-TI Gene Cardiomyopathy

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test gene MT-TI.

Test Name MT-TI Gene Cardiomyopathy fatal MT-TI related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test gene MT-TI
Test Details

MT-TI gene cardiomyopathy is a type of cardiomyopathy that is caused by mutations in the MT-TI gene. This gene provides instructions for making a type of RNA molecule called transfer RNA (tRNA), which is essential for protein synthesis within mitochondria.

Cardiomyopathy is a disease of the heart muscle that affects its structure and function, leading to symptoms such as fatigue, shortness of breath, and heart failure. In the case of MT-TI gene cardiomyopathy, the mutations in the MT-TI gene disrupt the normal function of tRNA, impairing protein synthesis within mitochondria and leading to mitochondrial dysfunction.

MT-TI related NGS genetic testing refers to Next-Generation Sequencing (NGS) technology used to analyze the DNA sequence of the MT-TI gene. This genetic test can identify mutations or variations in the MT-TI gene that may be associated with cardiomyopathy. By detecting these mutations, the test can help diagnose MT-TI gene cardiomyopathy and provide valuable information for treatment and management of the condition.

It is important to note that MT-TI gene cardiomyopathy is a fatal condition, meaning it can lead to severe complications and premature death. Early diagnosis through genetic testing can help guide appropriate medical interventions and monitoring to improve patient outcomes.